Global Bronchodilators Market, 2021-2027

July 2021 | 82 pages | ID: GAAF2E08BDAFEN
Gen Consulting Company

Abstracts

The global bronchodilators market is projected to grow at a compound annual growth rate (CAGR) of 6.07% during the forecast period 2021-2027, according to the new report published by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global bronchodilators market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, company share of market leaders, growth rate and market segments.

The bronchodilators market is segmented on the basis of indication, drug type, route of administration, and region. The bronchodilators market is segmented as below:

By Indication:

• asthma
• chronic obstructive pulmonary disease (COPD)
• others

By Drug Type:

• anticholinergics
• combination drugs
• phosphodiesterase inhibitors
• sympathomimetics

By Route Of Administration:

• inhalers
• injection
• oral

By Region:

• region
• Asia-Pacific
• Europe
• North America
• Middle East and Africa (MEA)
• South America

The market research report covers the analysis of key stake holders of the bronchodilators market. Some of the leading players profiled in the report include Abbott Laboratories, AstraZeneca PLC, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Roche Holding AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Vectura Group plc, among others.

*list is not exhaustive, request free sample to get a complete list of companies

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global bronchodilators market.
• To classify and forecast the global bronchodilators market based on indication, drug type, route of administration, and region.
• To identify drivers and challenges for the global bronchodilators market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global bronchodilators market.
• To conduct pricing analysis for the global bronchodilators market.
• To identify and analyze the profile of leading players operating in the global bronchodilators market.

Why Choose This Report

• Gain a reliable outlook of the global bronchodilators market forecasts from 2021 to 2027 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic

PART 5. GLOBAL MARKET FOR BRONCHODILATORS BY INDICATION

5.1 Asthma
  5.1.1 Market Size and Forecast
5.2 Chronic Obstructive Pulmonary Disease (Copd)
  5.2.1 Market Size and Forecast
5.3 Others
  5.3.1 Market Size and Forecast

PART 6. GLOBAL MARKET FOR BRONCHODILATORS BY DRUG TYPE

6.1 Anticholinergics
  6.1.1 Market Size and Forecast
6.2 Combination Drugs
  6.2.1 Market Size and Forecast
6.3 Phosphodiesterase Inhibitors
  6.3.1 Market Size and Forecast
6.4 Sympathomimetics
  6.4.1 Market Size and Forecast

PART 7. GLOBAL MARKET FOR BRONCHODILATORS BY ROUTE OF ADMINISTRATION

7.1 Inhalers
  7.1.1 Market Size and Forecast
7.2 Injection
  7.2.1 Market Size and Forecast
7.3 Oral
  7.3.1 Market Size and Forecast

PART 8. GLOBAL MARKET FOR BRONCHODILATORS BY REGION

8.1 Asia-Pacific
  8.1.1 Market Size and Forecast
8.2 Europe
  8.2.1 Market Size and Forecast
8.3 North America
  8.3.1 Market Size and Forecast
8.4 Middle East And Africa (Mea)
  8.4.1 Market Size and Forecast
8.5 South America
  8.5.1 Market Size and Forecast

PART 9. KEY COMPETITOR PROFILES

9.1 Abbott Laboratories
9.2 AstraZeneca PLC
9.3 Boehringer Ingelheim International GmbH
9.4 GlaxoSmithKline plc
9.5 Novartis AG
9.6 Pfizer Inc.
9.7 Roche Holding AG
9.8 Sanofi S.A.
9.9 Teva Pharmaceutical Industries Ltd.
9.10 Vectura Group plc
*LIST IS NOT EXHAUSTIVE

PART 10. PATENT ANALYSIS

10.1 Patent Statistics
10.2 Regional Analysis
10.3 Trends Analysis
DISCLAIMER
ABOUT GEN CONSULTING COMPANY